metformin analogs (HanAll Biopharma)

N/A

Report date: 2026/03/30 17:02:26

Base Information

Drug Namemetformin analogs (HanAll Biopharma)
Drug Alias Namebiguanide derivatives (Hanall)HL-153HL-148HL-149HL-146 +[6] 
ClassificationSmall molecules
Mechanisms of ActionAMP-activated protein kinases activators
TargetsAMP-activated protein kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHanAll Biopharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHanAll Biopharma Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A